Allspring Global Investments Holdings LLC Boosts Holdings in Alignment Healthcare, Inc. $ALHC

Allspring Global Investments Holdings LLC increased its position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) by 1.6% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 652,152 shares of the company’s stock after buying an additional 9,989 shares during the quarter. Allspring Global Investments Holdings LLC owned about 0.33% of Alignment Healthcare worth $9,267,000 at the end of the most recent reporting period.

Several other hedge funds also recently added to or reduced their stakes in ALHC. MCF Advisors LLC raised its position in Alignment Healthcare by 87.6% in the first quarter. MCF Advisors LLC now owns 2,165 shares of the company’s stock valued at $40,000 after purchasing an additional 1,011 shares during the period. Skandinaviska Enskilda Banken AB publ purchased a new stake in Alignment Healthcare in the 1st quarter valued at about $42,000. Signaturefd LLC raised its holdings in Alignment Healthcare by 142.6% in the 2nd quarter. Signaturefd LLC now owns 3,768 shares of the company’s stock valued at $53,000 after buying an additional 2,215 shares during the period. Amalgamated Bank lifted its position in Alignment Healthcare by 21.6% in the first quarter. Amalgamated Bank now owns 3,466 shares of the company’s stock valued at $65,000 after buying an additional 616 shares during the last quarter. Finally, Greenleaf Trust purchased a new position in Alignment Healthcare during the second quarter worth about $160,000. 86.19% of the stock is currently owned by hedge funds and other institutional investors.

Alignment Healthcare Stock Performance

NASDAQ:ALHC opened at $17.12 on Friday. Alignment Healthcare, Inc. has a 52 week low of $10.11 and a 52 week high of $21.06. The company has a fifty day simple moving average of $16.40 and a two-hundred day simple moving average of $15.62. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 2.29. The company has a market cap of $3.39 billion, a price-to-earnings ratio of -61.14 and a beta of 1.18.

Alignment Healthcare (NASDAQ:ALHC) last announced its quarterly earnings data on Wednesday, July 30th. The company reported $0.07 earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.07) by $0.14. Alignment Healthcare had a negative return on equity of 43.68% and a negative net margin of 1.53%.The business had revenue of $1.02 billion for the quarter, compared to analysts’ expectations of $960.25 million. During the same period last year, the firm earned ($0.13) earnings per share. The company’s revenue for the quarter was up 49.0% compared to the same quarter last year. Alignment Healthcare has set its FY 2025 guidance at EPS. Q3 2025 guidance at EPS. As a group, equities analysts anticipate that Alignment Healthcare, Inc. will post -0.69 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

A number of equities research analysts have recently issued reports on ALHC shares. Zacks Research raised shares of Alignment Healthcare from a “hold” rating to a “strong-buy” rating in a research note on Monday, September 29th. KeyCorp raised Alignment Healthcare from a “sector weight” rating to an “overweight” rating and set a $21.00 target price on the stock in a research report on Monday, August 25th. Weiss Ratings restated a “sell (d-)” rating on shares of Alignment Healthcare in a research note on Wednesday, October 8th. Barclays raised Alignment Healthcare from an “underweight” rating to an “equal weight” rating and lifted their price objective for the company from $9.00 to $13.00 in a research note on Thursday, July 31st. Finally, Wall Street Zen lowered Alignment Healthcare from a “buy” rating to a “hold” rating in a research note on Sunday, August 10th. Two investment analysts have rated the stock with a Strong Buy rating, seven have given a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, Alignment Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $19.05.

Insider Buying and Selling at Alignment Healthcare

In related news, insider Christopher J. Joyce sold 30,939 shares of the company’s stock in a transaction that occurred on Wednesday, September 10th. The shares were sold at an average price of $16.41, for a total transaction of $507,708.99. Following the sale, the insider directly owned 343,592 shares in the company, valued at approximately $5,638,344.72. This represents a 8.26% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Atlantic (Aln Hlth) L. General sold 6,246,096 shares of the firm’s stock in a transaction that occurred on Wednesday, September 17th. The shares were sold at an average price of $16.01, for a total transaction of $99,999,996.96. Following the completion of the sale, the director directly owned 24,596,079 shares in the company, valued at approximately $393,783,224.79. This trade represents a 20.25% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 7,443,207 shares of company stock valued at $119,848,080. 7.00% of the stock is currently owned by company insiders.

Alignment Healthcare Profile

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.